About Vivodyne
Vivodyne is a company based in Philadelphia (United States) founded in 2021 by Dan Huh. Vivodyne has raised $117.69 million across 3 funding rounds from investors including Khosla Ventures, CS Ventures and Kairos Ventures. Vivodyne offers products and services including Human Organ Models and Predictive AI. Vivodyne operates in a competitive market with competitors including Newcells Biotech, InSphero, Pandorum, Adapsyn and Cellesce, among others.
- Headquarter Philadelphia, United States
- Founders Dan Huh
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vivodyne, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$117.69 M (USD)
in 3 rounds
-
Latest Funding Round
$77.69 M (USD), Series A
Feb 03, 2025
-
Investors
Khosla Ventures
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vivodyne
Vivodyne offers a comprehensive portfolio of products and services, including Human Organ Models and Predictive AI.
Lab-grown tissues for realistic drug testing simulations
AI platform that optimizes therapies using human data
People of Vivodyne
Unlock access to complete
Funding Insights of Vivodyne
Vivodyne has successfully raised a total of $117.69M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $77.69 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vivodyne
Vivodyne has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Khosla Ventures, CS Ventures and Kairos Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life sciences, physical sciences, and technology companies
|
Locked | Locked | Locked | |
|
Investment in start-ups for global impact, with focus on B2B services and software solutions in India.
|
Locked | Locked | Locked |
Investor details for Vivodyne
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vivodyne
Investment portfolio details for Vivodyne
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vivodyne
Detailed financials for Vivodyne
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vivodyne Comparisons
Peer comparison for Vivodyne
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vivodyne
Vivodyne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newcells Biotech, InSphero, Pandorum, Adapsyn and Cellesce, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Induced pluripotent stem cell-derived organoid models are developed for research.
|
|
| Locked | Locked | Locked |
Cell-based assays and 3D microtissues for drug screening are developed.
|
|
| Locked | Locked | Locked |
Regenerative medicine and 3D tissues are developed for therapeutic uses.
|
|
| Locked | Locked | Locked |
Provider of computational tools for bacterial metabolomic and genomic data analysis
|
|
| Locked | Locked | Locked |
Scalable processes for organoid expansion are developed.
|
Detailed competitors of Vivodyne
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vivodyne
Complete news archive for Vivodyne
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivodyne
Vivodyne was founded in 2021.
Vivodyne is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Vivodyne is a funded company, having raised a total of $117.69M across 3 funding rounds to date.
Vivodyne was founded in 2021 in Philadelphia, United States, within the biotechnology sector. An AI-driven platform is utilized to culture human tissue models for drug discovery purposes. Single-cell 4D phenomics is integrated with a confocal microscope, alongside an automated robotic system that identifies potential drugs and cellular therapies. Operations focus on advancing preclinical testing through engineered biological models.
Vivodyne's top competitors include Newcells Biotech, InSphero and Parallel Bio.
Vivodyne offers Human Organ Models and Predictive AI.
Vivodyne has 8 investors. Key investors include Khosla Ventures, CS Ventures, Kairos Ventures, MBX Capital, and Bison Ventures.